{"nct_id":"NCT05401357","title":"Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.","status":"RECRUITING","status_verified_date":"2022-08","start_date":"2022-06-29","start_date_type":"ACTUAL","primary_completion_date":"2022-12","primary_completion_date_type":"ESTIMATED","completion_date":"2022-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AMRX"]}